Cannabidiol Oral Solution – A New Class of Antiseizure Medication

Abstract

1. Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy; 2. Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria; 3. Centre for Cognitive Neuroscience, Salzburg, Austria; 4. Department of Public Health, Health Services Research and Health Technology Assessment, University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria; 5. Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, ‘Gianna Gaslini’ Institute, University of Genoa, Genoa, Italy; 6. Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Verona, Italy; 7. Division of Neurology, ‘Franz Tappeiner’ Hospital, Merano, Italy